Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Rhea-AI Summary

Heartflow (Nasdaq: HTFL) announced management will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco on March 3, 2026.

The presentation is scheduled for 10:45 a.m. PT / 1:45 p.m. ET, with a live webcast and archived replay available via the company's Investor Relations website.

News Market Reaction – HTFL

+6.33%

40 alerts

+6.33% News Effect

+5.3% Peak in 2 hr 8 min

+$125M Valuation Impact

$2.09B Market Cap

0.3x Rel. Volume

On the day this news was published, HTFL gained 6.33%, reflecting a notable positive market reaction. Argus tracked a peak move of +5.3% during that session. Our momentum scanner triggered 40 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $125M to the company's valuation, bringing the market cap to $2.09B at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: March 3, 2026 Presentation time PT: 10:45 a.m. PT Presentation time ET: 1:45 p.m. ET

3 metrics

Conference date March 3, 2026 Morgan Stanley Technology, Media & Telecom Conference presentation date

Presentation time PT 10:45 a.m. PT Scheduled time for Heartflow fireside chat

Presentation time ET 1:45 p.m. ET Scheduled time for Heartflow fireside chat

Market Reality Check

Price: $25.10 Vol: Volume 2,986,499 is 1.52x...

high vol

$25.10 Last Close

Volume Volume 2,986,499 is 1.52x the 20-day average of 1,959,394, indicating elevated trading interest. high

Technical Shares at 22.27 are trading below the 200-day MA of 31.72 and 45.98% below the 52-week high.

Peers on Argus

HTFL gained 7.79% with elevated volume, while key peers showed mixed moves (e.g....

HTFL gained 7.79% with elevated volume, while key peers showed mixed moves (e.g., PRVA -1.6%, WAY +3.45%), supporting a stock-specific reaction rather than a broad sector shift.

Historical Context

5 past events · Latest: Feb 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 12	Registry expansion	Positive	-16.6%	Expanded GAMEFILM registry to additional retired pro athletes using AI plaque analysis.
Jan 06	Coverage expansion	Positive	+2.5%	Aetna began nationwide coverage with new Category I CPT code and RVU structure.
Jan 05	Conference participation	Neutral	+2.5%	Management presented at J.P. Morgan Healthcare Conference with webcast for investors.
Dec 18	Guideline endorsement	Positive	+6.5%	ACC/AHA statements highlighted quantitative plaque assessment and Heartflow pathway in CAD care.
Dec 11	Clinical outcomes data	Positive	+1.0%	Large FFRCT analyses showed prognostic power and health‑economic savings in >90,000 patients.

Pattern Detected

Most prior positive clinical and reimbursement updates saw modest gains, but the GAMEFILM registry expansion drew a sharp negative reaction, indicating occasionally contrarian trading around news.

Recent Company History

Over the past few months, Heartflow has reported several positive developments, including expanded scientific support for its plaque analysis, large real‑world FFRCT outcomes and cost‑savings data, and broader U.S. payer coverage with Aetna using new CPT code 75577. It also expanded the GAMEFILM registry to additional professional athlete groups. Conference participation, like J.P. Morgan and now Morgan Stanley TMT, has accompanied these milestones. The current conference update follows a -16.55% reaction to the registry news, contrasting with earlier modest gains.

Market Pulse Summary

The stock moved +6.3% in the session following this news. A strong positive reaction aligns with per...

Analysis

The stock moved +6.3% in the session following this news. A strong positive reaction aligns with periods when HTFL traded actively around visibility events, though past responses have varied. Prior scientific and reimbursement wins saw modest gains, while the GAMEFILM registry expansion coincided with a -16.55% move. A conference‑driven move of around 7.79% could reflect renewed interest, but the stock still trades well below its 52‑week high, and prior volatility suggests moves may not always persist.

Key Terms

coronary artery disease (cad)

1 terms

coronary artery disease (cad) medical

"the leader in AI technology for coronary artery disease (CAD), today announced"

Coronary artery disease (CAD) is the gradual build-up of fatty deposits inside the blood vessels that supply the heart, narrowing them and reducing blood flow; think of it like rusted or clogged pipes feeding an engine. It matters to investors because CAD drives demand for drugs, devices, procedures, and long‑term care, influences healthcare costs and insurer payouts, and can affect workforce productivity and the valuation of companies in diagnostics, treatment development, and medical services.

AI-generated analysis. Not financial advice.

MOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley Technology, Media & Telecom Conference. The presentation will take place in San Francisco, CA, on Tuesday, March 3, 2026, at 10:45 a.m. PT / 1:45 p.m. ET.

A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at https://ir.heartflow.com.

About Heartflow’s Technology and Research
Heartflow’s technology is redefining precision cardiovascular care through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,400 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by ACC/AHA guidelines and supported by more than 600 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 500,000 patients worldwide.¹ Key benefits include:

• Proprietary data pipeline: Built from more than 160 million annotated CTA images, Heartflow’s data foundation powers advanced AI models that deliver highly accurate, reproducible insights across diverse patient populations.
• Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 200 studies assessing over 365,000 patients. Proven in real-world practice with reproducibility and accuracy, Heartflow’s coronary CTA image acceptance rates exceed 97%.
• Seamless clinical integration via upgraded workflow: Heartflow delivers final quality-reviewed analyses instantly upon order, enabling clinicians to move from diagnosis to decision without delay.
• Quality system, global security and patient-data integrity compliance: Heartflow meets or exceeds leading international standards, including HITRUST, SOC 2 Type 2, ISO 13485, and ISO 27001.
  
  

About Heartflow, Inc.
Heartflow is transforming coronary artery disease from the world’s leading cause of death into a condition that can be detected early, diagnosed accurately, and managed for life. The Heartflow One platform uses AI to turn coronary CTA images into personalized 3D models of the heart, providing clinically meaningful, actionable insights into plaque location, volume, and composition and its effect on blood flow — all without invasive procedures. Discover how we’re shaping the future of cardiovascular care at heartflow.com.

Investor Contact
Nick Laudico
nlaudico@heartflow.com

Media Contact
Elliot Levy
elevy@heartflow.com

____________________
¹Gulati, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation & Diagnosis of Chest Pain. J Am Coll Cardiol.

FAQ

When is Heartflow (HTFL) presenting at the Morgan Stanley Technology, Media & Telecom Conference?

Heartflow will present on March 3, 2026 at 10:45 a.m. PT / 1:45 p.m. ET. According to Heartflow, members of management will participate in a fireside chat on that date in San Francisco and the schedule is published by the company.

Where will the Heartflow (HTFL) fireside chat at Morgan Stanley take place?

The fireside chat will take place in San Francisco, CA on March 3, 2026. According to Heartflow, the live session is hosted at the conference venue and the company will provide a webcast via its Investor Relations website.

How can investors watch Heartflow (HTFL) at the Morgan Stanley TMT Conference?

Investors can watch a live webcast and archived replay on Heartflow's Investor Relations website. According to Heartflow, the company will post both a live stream and an archived version for later viewing on its IR site.

Who from Heartflow (HTFL) will participate in the Morgan Stanley fireside chat?

Members of Heartflow's management team will participate in the fireside chat on March 3, 2026. According to Heartflow, company management, rather than external speakers, will lead the discussion at the Morgan Stanley conference session.

What time should investors tune in for Heartflow (HTFL) at the Morgan Stanley conference?

Tune in at 10:45 a.m. PT / 1:45 p.m. ET on March 3, 2026 for the live fireside chat. According to Heartflow, the session starts at that scheduled time and will be available live and later as an archived replay.

Will Heartflow (HTFL) provide an archived replay of its Morgan Stanley presentation?

Yes, an archived replay will be available on Heartflow's Investor Relations website after the event. According to Heartflow, both a live webcast and an archived version of the fireside chat will be posted for investor access.